Neeraj Agarwal, MD, reviews the case of a 73-year-old man with unresectable, locally advanced urothelial carcinoma and discusses latest data and treatment approaches.
Case Overview: A 73-Year-Old Male With Urothelial Carcinoma
Initial presentation
Clinical workup
Treatment
Tailoring Treatment for High-Risk Bladder Cancer: Beyond BCG
February 2nd 2024In an interview with Targeted Oncology, Stephen Williams, MD, discussed a retrospective cohort study analyzing intravesical gemcitabine usage vs Bacillus Calmette-Guérin for the treatment of high-risk non-muscle invasive bladder cancer.
Read More